Samuel R. Nussbaum, MD, is executive vice president for clinical health policy and chief medical officer for WellPoint, Inc. He is the key spokesperson and policy advocate for WellPoint. He oversees corporate medical and pharmacy policy to ensure the provision of clinically proven effective care. Dr. Nussbaum collaborates with industry leaders, physicians, hospitals, and national policy and health care organizations to shape an agenda for quality, safety, and clinical outcomes and to improve patient care for WellPoint’s 34 million medical members nationwide. In addition, Dr. Nussbaum works closely with WellPoint business units to advance international and innovative health care services strategy and development.